Body Vision Medical out of Ramat Ha Sharon, Israel is releasing its LungVision platform for planning, navigating to, and targeting small pulmonary nodules within the peripheral regions of the lungs. The product integrates into bronchoscopy suites and provides a step-by-step process that the company claims doesn’t require a large learning curve.
Using augmented reality tools, the LungVision platform overlays the location of pathways and nodules on the fluoroscope image, that would otherwise be invisible during bronchoscopy. The software constantly compensates for the breathing of the patient, with its visual overlay constantly staying in tune with the fluoro image.
The system relies on a disposable navigation catheter that can work with existing endo-bronchial tools and endotherapy accessories.
“Body Vision provides a great tool that has changed the way we approached peripheral nodules. Its unique technology creates augmented reality with the ability to see fluoroscopically invisible lesions and the pathways under the live fluoro, while tracking a patient breathing,” said D. Kyle Hogarth, MD, FCCP, President of the Society for Advanced Bronchoscopy, Associate Professor of Medicine, Director of Bronchoscopy at the University of Chicago, in a statement. “Once the technology has guided us to the lesion, we confirm the lesion’s relationship to the airway with radial-EBUS. We then use our off-the-shelf biopsy instruments via the LungVision™ catheter. The augmented fluoro image, integrated with the radial EBUS images, allows us to obtain tissue samples with continuous real-time confirmation of location. The beauty of it all is how simple and elegant the technology is.”
Here’s a presentation about LungVision at CHEST 2017, Toronto, Canada:
Via: Body Vision…